In the Journals Plus

Smoking linked to poor neoadjuvant chemotherapy response, recurrence in bladder cancer

January 16, 2019
Cigarette smoking appeared significantly associated with poor pathological response to cisplatin-based neoadjuvant chemotherapy among patients with…
In the Journals

Smoking, obesity, older age predict increased VTE risk

January 16, 2019
Older age, smoking and obesity were consistently associated with increased risk for venous thromboembolism, according to a study published in JAMA
In the Journals

Endoscopic full-thickness resection feasible, safe for early colorectal cancer

January 16, 2019
Using endoscopic full-thickness resection can help stratify patients with early colorectal cancer and allows patients with low-risk lesions to avoid…
FDA News

FDA grants breakthrough therapy designation to zanubrutinib for mantle cell lymphoma

January 16, 2019
The FDA granted breakthrough therapy designation to zanubrutinib for the treatment of adults with mantle cell lymphoma who received at least one…
In the Journals Plus

Financial incentives may influence oncologists’ practice patterns

January 15, 2019
Some oncologists may alter treatment recommendations for patients in some cases based on personal revenue considerations, according to results of a…
Meeting News

Pembrolizumab reduces mortality risk in advanced PD-L1-positive esophageal cancer

January 15, 2019
Pembrolizumab significantly improved OS compared with chemotherapy as second-line treatment for patients with advanced or metastatic esophageal or…

Task force: Medications to reduce breast cancer risk ‘are not for everyone’

January 15, 2019
Medications intended to reduce risk for breast cancer should be offered to women with an elevated risk for the disease but a low risk for adverse…
FDA News

FDA approves Cabometyx for treatment-experienced patients with HCC

January 15, 2019
Exelixis has announced it has received FDA approval for Cabometyx to treat patients with hepatocellular carcinoma who previously underwent treatment…
In the Journals Plus

Treatment at academic centers yields survival benefit in metastatic NSCLC

January 15, 2019
In the JournalsPerspective

‘Remarkably low’ uptake of shared decision-making visits for lung cancer screening

January 15, 2019
Participation in shared decision-making visits before low-dose CT screening for lung cancer was “remarkably low” among Medicare…
In the Journals Plus

Black women, poor face barriers to breast cancer screening despite interventions

January 14, 2019
Black women, women living in poverty, and women who expressed deep distrust of the health care system appeared less likely to report barriers to…
In the Journals Plus

No link between ADT, dementia among veterans with prostate cancer

January 14, 2019
Androgen deprivation therapy did not appear to increase risk for dementia, vascular dementia or Alzheimer disease among veterans with nonmetastatic…
In the Journals

Medicare Part D could save $14.4B using VA drug prices

January 14, 2019
If Medicare Part D paid prices for prescription medications similar to what the Department of Veterans Affairs pays, there could be an estimated…
In the Journals Plus

Complication rates after invasive diagnostic lung procedures twice as high in community setting

January 14, 2019
Complications after invasive diagnostic procedures for lung abnormalities occurred twice as often in the real-world setting than in clinical trials…

Study of varlitinib for first-line gastric cancer treatment misses primary endpoint

January 14, 2019
A phase 2 study designed to compare varlitinib with placebo as first-line treatment for certain patients with gastric cancer failed to meet its…
Perspective

HHS task force outlines best practices for pain management, seeks input

January 14, 2019
The Pain Management Best Practices Inter-Agency Task Force — an entity within HHS — recently issued a 91-page report detailing best…

Dana-Farber Cancer Institute appoints executive vice president

January 13, 2019
James Terwilliger has been appointed executive vice president and chief operating officer at Dana-Farber Cancer Institute. His appointment will be…

Cancer Treatment Centers of America appoints chief medical officer

January 12, 2019
Julian Schink, MD, has been appointed chief medical officer for Cancer Treatment Centers of America. Schink joined Cancer Treatment Centers of…

First patient enrolled in pancreatic cancer study

January 12, 2019
The Henry Ford Cancer Institute has announced that it has enrolled the first patient in a new trial to test the effectiveness of precise, higher dose…
In the Journals Plus

Organ-sparing treatment strategy appears promising in early-stage rectal cancer

January 11, 2019
Neoadjuvant chemoradiotherpy followed by transanal endoscopic microsurgery may be a viable alternative to conventional total mesorectal excision for…